QUANTUM-SI INC
QSINASDAQTrading Snapshot
- Day Range
- $0.89 β $1.04
- 52-Week Range
- $0.69 β $1.81
- Volume (shares)
- 7,822,106
- Avg Volume (shares)
- β
- Shares Outstanding
- 218.9M
- Next Earnings
- 2027-03-02
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- $212,000
- P/E Ratio
- β
- P/S Ratio
- 124.5x
- EPS (TTM)
- $-0.46
- Dividend Yield
- β
- Dilution (1yr)
- +35.2%
QUANTUM-SI INC
QSIAbout QUANTUM-SI INC
Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry. This system is specifically applied to the field of proteomics, paving the way for next-generation protein sequencing. Established in 2013, Quantum-Si's headquarters are located in Guilford, Connecticut.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates

Quantum-Si Achieves Historic Milestone in Protein Sequencing with Single-Molecule Detection of All 20 Amino Acids on Proteusβ’
Achievement establishes complete amino acid detection as a new benchmark for single-molecule protein sequencing Capability is expected to lay the foundation for reference-free protein identification and expanded analysis

QUANTUM X AND EVEREST CLOUD PARTNER TO BRING QUANTUM AND AI COMPUTE TO SIX SOUTH ASIAN MARKETS
Channel partnership MOU gives EntangleX a route to banks, telecom operators, universities and data centers in Nepal, India, Bangladesh, Bhutan, Sri Lanka and the Maldives, backed by a growing operating revenue base LOCUS

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn., Nov. 13, 2026 (GLOBE NEWSWIRE) -- Quantum-Si IncorporatedΒ (Nasdaq: QSI) (βQuantum-Si,β βQSIβ or the βCompanyβ),Β a proteomics company redefining protein analysis through single-molecule protein sequencing

Quantum-Si Q3 Earnings Call Highlights
Quantum-Si NASDAQ: QSI reported lower third-quarter revenue and narrowed its net loss as it prepared for the planned second-quarter 2027 commercial launch of its Proteus protein sequencing platform.

Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript
Quantum-Si incorporated (QSI) Q3 2026 Earnings Call Transcript

Quantum-Si Incorporated (QSI) Reports Q3 Loss, Misses Revenue Estimates
Quantum-Si Incorporated (QSI) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compares to a loss of $0.17 per share a year ago.